Technical Resources

  Poster Publications

Respiratory Viral Infections
Emerging requirements for infectious disease IVD quality control material
Human Papillomavirus (HPV) Infections
Performance of High Risk HPV Single Analyte and Multiplex Panel External Quality Controls for Verification of Extended Genotyping on the BD Onclarity ™HPV Assay
Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Controls
Abbott: Evaluation of Commercially Available HPV Panels with the Alinity m HR HPV Investigational Use Only (IUO) Assay
Abbott: Performance Characteristics of the Alinity m HR HPV Investigational Use Only (IUO) Assay and Comparison to the Cobas HPV 6800 Assay
Evaluating Diagnostic Workflows for HPV -Positive Oropharyngeal Squamous Cell Carcinoma Detection Using Simulated Specimens Mounted on Slides
Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6/E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods
Performance of full and extended genotyping assays using a new high-risk HPV multiplex panel
Sexually Transmitted Infections (STIs)
Mycoplasma genitalium, Drug Resistance, Nucleic Acid Detection; Introducing a New External Quality Assessment Scheme
Novel Mycoplasma genitalium (Mgen) and AMR Mgen A2059G Materials for use in a Cross-Platform NAAT Quality Control
Performance of NAAT that detect MGEN using Swab Quality Controls
Evaluating the Performance of Emerging STI Point of Care Assays Using Novel, Room Temperature Stable CT/NG/TV/MG Positive Swab Quality Control Materials
SARS Complete Infections
Simulated swab specimens for whole workflow quality control of SARS-CoV-2 molecular diagnostic testing
Advanced SARS-CoV-2 Variants of Concern (VOC) whole-genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples
Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as a cross-platform EQA sample and as a prospective Quality Control
Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls
Novel SARS-CoV-2 Full-Genome Material for Use in a Swab-Based Formulation as a Multi-Platform NAAT Quality Control
Respiratory virus multiplex formulations desiccated on Copan’s FLOQSwab® for use as cross-platform compatible EQA samples and laboratory Quality Control
Hepatitis C
Novel Hepatitis C Virus External Quality Control That Is Stable at Ambient Temperature And Suitable For Use In Low-Resource Settings
Gastrointestinal Infections
New External Quality Assessment Program for Laboratories that Detect H. pylori and Antimicrobial Resistant Markers Using Nucleic Acid Amplification Test Methods
Gential Ulcer Infections
FFPE HSV-1 and HSV-2 simulated tissue sections mounted on slides for use as prospective quality controls in IHC and qPCR workflows

  White Papers

High-Risk HPV Quality Controls are Needed to Uphold Clinical Laboratory Quality Standards
Expected stability of REDx™FLOQ® SARS-CoV-2 Swab Positive Control and REDx™FLOQ® SARS-CoV-2 Swab Negative Control in various sample transport media and storage conditions
Use of REDx™FLOQ® SARS-CoV-2 Ag Swab Positive Control and REDx™FLOQ® Respiratory Swab Negative Control as Quality Control by POC devices in various testing conditions
Expected stability of REDx™FLOQ® SARS-CoV-2 Swab Positive Control and REDx™FLOQ® SARS-CoV-2 Swab Negative Control in various sample transport media and storage conditions.